Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Disease model: pulmonary tuberculosis.

D N McMurray1

  • 1Department of Medical Microbiology and Immunology, Texas A&M University System Health Science Center, Reynolds Medical Building, College Station, TX 77843-1114, USA. dmcmurray@tamu.edu

Trends in Molecular Medicine
|April 5, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Novel Therapeutic and Prophylactic Vaccine (HVJ-Envelope / Hsp65 DNA + IL-12 DNA) against Tuberculosis Using the Cynomolgus Monkey Model.

Procedia in vaccinology·2020
Same author

A Novel Therapeutic and Prophylactic Vaccine against Tuberculosis Using the Cynomolgus Monkey Model and Mouse Model.

Procedia in vaccinology·2020
Same author

Obesity promotes colonic stem cell expansion during cancer initiation.

Cancer letters·2015
Same author

The in vivo immunomodulatory effect of recombinant tumour necrosis factor-alpha in guinea pigs vaccinated with Mycobacterium bovis bacille Calmette-Guérin.

Clinical and experimental immunology·2011
Same author

Coxiella burnetii isolates cause genogroup-specific virulence in mouse and guinea pig models of acute Q fever.

Infection and immunity·2009
Same author

Experimental exposure of cattle to a precise aerosolised challenge of Mycobacterium bovis: a novel model to study bovine tuberculosis.

Tuberculosis (Edinburgh, Scotland)·2007
Same journal

Hyocholic acids: Third bile acids for neonatal health.

Trends in molecular medicine·2026
Same journal

Clonal hematopoiesis in Alzheimer's brain: Protective, pathogenic, and context-dependent?

Trends in molecular medicine·2026
Same journal

Targeting amino acid metabolism in hepatocellular carcinoma.

Trends in molecular medicine·2026
Same journal

Turning perfusion into repair through ferroptosis blockade.

Trends in molecular medicine·2026
Same journal

CaMKK2: A tumor stress-integration node.

Trends in molecular medicine·2026
Same journal

Precision gene editing: From proof-of-concept to curative therapies.

Trends in molecular medicine·2026
See all related articles

New tuberculosis (TB) drugs, vaccines, and diagnostics are essential for disease control. Advances in genomics and animal models accelerate the search for novel TB interventions.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Genomics

Background:

  • Tuberculosis (TB) control faces challenges including HIV co-infection, drug resistance, and vaccine limitations.
  • The development of new drugs, vaccines, and diagnostic tests is crucial for effective TB management.
  • The Mycobacterium tuberculosis genome sequence (1998) has enabled targeted research.

Purpose of the Study:

  • To highlight the need for novel interventions in tuberculosis control.
  • To emphasize the role of genomics and animal models in advancing TB research.

Main Methods:

  • Leveraging the Mycobacterium tuberculosis genome sequence for gene discovery.
  • Utilizing biologically relevant animal models for pulmonary TB research.

Related Experiment Videos

Main Results:

  • Genomic data facilitates the identification of virulence genes, drug targets, and vaccine antigens.
  • Animal models provide crucial insights into pulmonary TB pathogenesis and treatment efficacy.

Conclusions:

  • Continued research into novel drugs, vaccines, and diagnostics is imperative for TB control.
  • Genomic and animal model advancements are key to developing effective new TB interventions.